Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.050
0.00 (0.00%)
At close: Oct 29, 2024, 4:00 PM
1.984
-0.066 (-3.22%)
After-hours: Oct 29, 2024, 6:41 PM EDT
Cellectar Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 73 | 34 | 16 | 41 | 94 | 21 | |
Market Cap Growth | 821.80% | 112.09% | -60.44% | -57.05% | 346.77% | 186.68% | |
Enterprise Value | 51 | 35 | -0 | 2 | 77 | 10 | |
Last Close Price | 2.05 | 2.77 | 1.71 | 6.64 | 20.80 | 22.50 | |
PE Ratio | - | -0.89 | -0.42 | -1.53 | -2.73 | -1.23 | |
PB Ratio | 7.48 | -25.10 | 1.03 | 1.23 | 1.72 | 2.33 | |
P/FCF Ratio | -3.26 | -1.02 | -0.63 | -1.79 | -6.75 | -1.80 | |
P/OCF Ratio | -3.33 | -1.05 | -0.64 | -1.80 | -6.78 | -1.81 | |
EV/EBITDA Ratio | -2.99 | -0.90 | 0.01 | -0.08 | -5.11 | -0.68 | |
EV/EBIT Ratio | -2.97 | -0.90 | 0.01 | -0.08 | -5.06 | -0.67 | |
EV/FCF Ratio | -3.18 | -1.05 | 0.01 | -0.09 | -5.53 | -0.81 | |
Debt / Equity Ratio | 0.02 | -0.41 | 0.04 | 0.01 | 0.01 | 0.06 | |
Debt / FCF Ratio | -0.01 | -0.02 | -0.02 | -0.01 | -0.03 | -0.05 | |
Quick Ratio | 2.46 | 0.74 | 3.59 | 8.95 | 16.04 | 3.83 | |
Current Ratio | 2.54 | 0.81 | 3.71 | 9.16 | 16.26 | 4.11 | |
Return on Equity (ROE) | -304.38% | -536.81% | -117.82% | -54.92% | -47.28% | -126.28% | |
Return on Assets (ROA) | -91.47% | -144.66% | -61.26% | -31.47% | -26.95% | -64.91% | |
Return on Capital (ROIC) | -152.45% | -318.13% | -72.82% | -34.06% | -29.49% | -77.56% | |
Earnings Yield | -69.37% | -111.59% | -178.21% | -59.46% | -15.98% | -66.66% | |
FCF Yield | -53.67% | -97.66% | -158.57% | -55.98% | -14.82% | -55.43% | |
Buyback Yield / Dilution | -100.67% | -73.22% | -27.09% | -180.20% | -158.14% | -159.12% | |
Total Shareholder Return | -100.67% | -73.22% | -27.09% | -180.20% | -158.14% | -159.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.